Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4

被引:86
作者
Katz, G [1 ]
Markel, G [1 ]
Mizrahi, S [1 ]
Arnon, TI [1 ]
Mandelboim, O [1 ]
机构
[1] Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
关键词
D O I
10.4049/jimmunol.166.12.7260
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NK cells are cytotoxic to virus-infected and tumor cells that have lost surface expression of class I MHC proteins. Target cell expression of class I MHC proteins inhibits NK cytotoxicity through binding to inhibitory NK receptors. In contrast, a similar family of activating NK receptors, characterized by the presence of a charged residue in their transmembrane portion and a truncated cytoplasmic tail, augment lysis by NK cells when ligated by an appropriate class I MHC protein. However, the class I MHC specificity of many of these activating NK receptors is still unknown. Here, we show enhanced lysis of HLA-Cw4 but not HLA-Cw6-expressing cells, by a subset of NK clones. This subset may express killer cell Ig-like receptor two-domain short tail number 4 (KIR2DS4), as suggested by staining with various mAb. It is still possible, however, that these clones may express receptors other than KIR2DS4 that might recognize HLA-Cw4. Binding of KIR2DS4-Ig fusion protein to cells expressing HLA-Cw4 but not to those expressing HLA-Cw6 was also observed. The binding of KIR2DS4-Ig to HLA-Cw4 is weaker than that of killer cell Ig-like receptor two-domain long tail number 1 (KIR2DL1)-Ig fusion protein; however, such weak recognition is capable of inhibiting lysis by an NK transfectant expressing a chimeric molecule of KIR2DS4 fused to the transmembrane and cytoplasmic portion of KIR2DL1. Residue alpha 14 is shown to be important in the KIR2DS4 binding to HLA-Cw4. Implications of the role of the activating NK receptors in immunosurveillance are discussed.
引用
收藏
页码:7260 / 7267
页数:8
相关论文
共 35 条
[1]   Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules [J].
Biassoni, R ;
Pessino, A ;
Malaspina, A ;
Cantoni, C ;
Bottino, C ;
Sivori, S ;
Moretta, L ;
Moretta, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) :3095-3099
[2]   STRUCTURE OF THE HUMAN CLASS-I HISTOCOMPATIBILITY ANTIGEN, HLA-A2 [J].
BJORKMAN, PJ ;
SAPER, MA ;
SAMRAOUI, B ;
BENNETT, WS ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1987, 329 (6139) :506-512
[3]   Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand [J].
Boyington, JC ;
Motyka, SA ;
Schuck, P ;
Brooks, AG ;
Sun, PD .
NATURE, 2000, 405 (6786) :537-543
[4]  
Braud VM, 1999, CURR TOP MICROBIOL, V244, P85
[5]   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[6]  
Campbell KS, 1998, EUR J IMMUNOL, V28, P599, DOI 10.1002/(SICI)1521-4141(199802)28:02<599::AID-IMMU599>3.0.CO
[7]  
2-F
[8]   The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells [J].
Cohen, GB ;
Gandhi, RT ;
Davis, DM ;
Mandelboim, O ;
Chen, BK ;
Strominger, JL ;
Baltimore, D .
IMMUNITY, 1999, 10 (06) :661-671
[9]   A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells [J].
Colonna, M ;
Nakajima, H ;
Navarro, F ;
López-Botet, M .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (03) :375-381
[10]   A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells [J].
Colonna, M ;
Navarro, F ;
Bellon, T ;
Llano, M ;
Garcia, P ;
Samaridis, J ;
Angman, L ;
Cella, M ;
LopezBotet, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (11) :1809-1818